
Keywords: POMC; pro-opiomelanocortin; NPY; neuropeptide Y; AgRP; agouti-related peptide; PCOS; polycystic ovary syndrome; BAT; brown adipose tissue; WAT; white adipose tissue; Myf5; myogenic factor 5; PRDM16; PRD1-BF1-RIZ1 homologous domain containing 16; UCP1; the